IBRX ImmunityBio Inc

$IBRX So my brother has 11k shares and I tell him to not sell one penny. He has had a hard life. But 11k shares could put him in very nice place not too long from now. I am leaning on his ass to just leave it alone. He is going to be very happy. I think he will listene.

$IBRX Hey, slow night. But we now know that we will be the dominant leader in Bladder cancer for a good while. First line and all the way down with first line approval coming. So now add Lung cancer. It has already been approved in Saudi Arabia, and it is larger than Bladder Cancer. Just those 2 indications put us at 80pps at least, the very least. So now we start talking about all of the other cancers. But the biggies are sepsis and Lymphopenia. We are in for a huge ride. Very huge. Love you all.

$IBRX Anybody excited?! The improvement was strong enough that the IDMC stopped further enrollment Because the difference in DOR was already statistically meaningful: The Independent Data Monitoring Committee (IDMC) determined additional patient enrollment was not needed. The trial already had sufficient statistical power to detect the prespecified treatment effect. This is an important clue: Stopping enrollment early in a randomized registrational trial due to efficacy is rare and implies a clear, favorable signal. This is one of the strongest early signals you can get in a randomized registrational trial.

$IBRX Glad October is behind us! November should bring some interesting catalysts. Been here since the $2 days, and what a ride! Shorts have made it frustrating, but the fundamental picture and, more importantly, Patrick's mission to change cancer treatment remain the real reasons we're all here — to believe in that vision, be part of the journey as investors, and ultimately be rewarded for it. Eventually, I believe institutions will lead our charge and flush out the short-selling trading crowd. With big tech getting hammered today, our 5% drop isn't exactly a disaster. Bigger picture, guys! And after blocking half of StockTwits 😂, I've found a great bunch of smart, funny, positive people who make this rollercoaster a lot more enjoyable every day. Thanks to you all. Here's to November! 🍻🚀

$IBRX - just bought another 115 shares after hours at $8.78…. I never do that, but something was telling me to.

$IBRX BTIG's Jeet Mukherjee kept his Buy rating on IBRX with the same $12 price target. That's a reiteration, not an upgrade. He pointed to Anktiva's $50.7M quarterly sales, which beat estimates and made eight straight quarters of growth, plus the QUILT-2.005 data and supplemental filing still on track. The report came out Oct 29 and was posted Oct 30. MarketBeat now shows a Moderate Buy consensus from 7 analysts with an average target of $16.

$IBRX FDA approved meant absolutely nothing, yet….when ya’ll understand how manipulated this US stock market is, you can actually breath and know it’s coming. Not on our timeline but actual physical financials and SEC docs are required. Don’t be naive, nothing that happens is real, until results are disclosed. In the meantime, know what you hold.

$IBRX Block out the near-term market noise. Focus on why you are here. Huge near-term dynamics. GL$$$$😎

The Orchestration Hypothesis: Could the future of cancer immunotherapy depend on timing, sequencing, and complementary mechanisms? Consider the potential synergy between: DCVax-L / Versamune: Priming the immune system to recognize tumor antigens. ANKTIVA (IL-15): Expanding and sustaining cytotoxic lymphocytes. PDS0301 (IL-12): Modifying the tumor microenvironment to support immune-cell activity. Like an orchestra, each instrument has a distinct purpose. But the conductor—coordinating the sequence, timing, and intensity—may be just as important as the individual instruments. Could this approach generate a more durable antitumor immune response? This is a conceptual hypothesis, not a clinically validated combination or treatment recommendation. Further preclinical and clinical research would be necessary. $IBRX $PDSB $NWBO

$IBRX Look on Fox News Joey Jones made the Perfect statement. If un-ethical behavior was a crime,Washington DC would be empty...We see same behavior at FDA and SEC, but now with all these websites we see that many of us share the same opinion....It is sad that behaving honestly is now viewed as a non desirable quality

$IBRX I think that the interesting thing about this election cycle is that the republicans are increasingly refusing to participate in the polling data. So the data out there is not reliable. So now today we saw that republicans pre election have voted more than ever before. So this will be very interesting. I will be staying up late on Tuesday.

$IBRX $PDSB $XBI Pretty much everyone on X is saying biotech stocks are about to go apeshit. And now Elon Musk himself is tweeting about it. Buckle up. Watch PDSB double from here quickly. Also watching $NAUT and $QSI for the double as well. 🤑

$IBRX If the dems win control of the house and senate, expect the stock market to drop another 10-15%. They hate capitalism and will create gridlock.

$IBRX An update on the Phase 2b glioblastoma trial is imminent. It involved 22 participants randomized 1:1 (Arm A: NAI + bevacizumab + TTFields; Arm B: NAI + bevacizumab + TTFields + PD-L1 t-haNK) The goal is to see if adding PD-L1 t-haNK in arm B of the trial would increase overall survival. Data is to be read out after 6 months that ended in September, so it could happen any day now. Earlier in May, at the 2.3 month point in the Phase 2B, nobody had died.

$IBRX Congrats to IOVA it’s spiking. Unfortunately, I sold early at $9 that’s why you don’t sell I made money but lost a lot of opportunity to make more. Our time will also come I pray we have spectacular earnings that causes the biggest squeeze possible. GLTAL

$IBRX Last thing we need is “Democrats” getting both the house and Senate….One of the Two is fine, but they have no agenda other than impeach, spend and push crazy social policy.

$IBRX November is just a couple of days away and super excited about Naive data, sale and other updates from our superhero Dr PSS. $14-15 per share in November is within reach if both are positive. Today is just a fart on the trip to the moon. IBRX is totally de-risked clinically. The only risk is the negative energy from shorts and paid bashers. Feel good holding ibrx long term.

$IBRX word to the wise -- if you are on the sidelines to enter or add, just buy now. One day you will wake up and we will be up >100%, and at that point it will feel too late, regrets, etc. Life's short... let's cure cancer and our financial situations together... coming sooner than you think 🙌

$IBRX So glad October is over! A highly volatile month = highly manipulated. Next week we are welcoming a November to remember ER, Naive topline results readout and potentially other surprises in store. There will be a lot to be Thankful for 🦃!

$IBRX AFTER HOURS EXPLOSION: With more than 21k contracts for the monthly option I would not be surprised if say the doc sends a NUKE PR earnings to have exceeded 100m for 3rd Q that would cause more than firecracker it would cause EXPLOSION 💥 could cause a squeeze. I am praying he destroys all the Cocoroaches and force them to buy shares and cover. GLTAL